Company: DAI – Fleming Fund

DAI – Fleming Fund is a prominent initiative in Pakistan aimed at strengthening antimicrobial resistance (AMR) surveillance. By partnering with local and national health organizations, it focuses on enhancing data collection and analysis related to AMR. The program provides critical support for policy development and promotes best practices in infection prevention and control. DAI’s comprehensive approach not only bolsters public health initiatives but also aligns with global health standards to ensure proper antimicrobial use and ultimately safeguard communities across Pakistan.